196 related articles for article (PubMed ID: 36975998)
21. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.
Pham CD; Iqbal N; Bolden CB; Kuykendall RJ; Harrison LH; Farley MM; Schaffner W; Beldavs ZG; Chiller TM; Park BJ; Cleveland AA; Lockhart SR
Antimicrob Agents Chemother; 2014 Aug; 58(8):4690-6. PubMed ID: 24890592
[TBL] [Abstract][Full Text] [Related]
22. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.
Chow NA; Muñoz JF; Gade L; Berkow EL; Li X; Welsh RM; Forsberg K; Lockhart SR; Adam R; Alanio A; Alastruey-Izquierdo A; Althawadi S; Araúz AB; Ben-Ami R; Bharat A; Calvo B; Desnos-Ollivier M; Escandón P; Gardam D; Gunturu R; Heath CH; Kurzai O; Martin R; Litvintseva AP; Cuomo CA
mBio; 2020 Apr; 11(2):. PubMed ID: 32345637
[No Abstract] [Full Text] [Related]
23. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.
Jacobs SE; Jacobs JL; Dennis EK; Taimur S; Rana M; Patel D; Gitman M; Patel G; Schaefer S; Iyer K; Moon J; Adams V; Lerner P; Walsh TJ; Zhu Y; Anower MR; Vaidya MM; Chaturvedi S; Chaturvedi V
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0005322. PubMed ID: 35770999
[TBL] [Abstract][Full Text] [Related]
24. Adaptation of the emerging pathogenic yeast
Lara-Aguilar V; Rueda C; García-Barbazán I; Varona S; Monzón S; Jiménez P; Cuesta I; Zaballos Á; Zaragoza Ó
Virulence; 2021 Dec; 12(1):1400-1417. PubMed ID: 34180774
[No Abstract] [Full Text] [Related]
25. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
[TBL] [Abstract][Full Text] [Related]
26. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.
Staab JF; Neofytos D; Rhee P; Jiménez-Ortigosa C; Zhang SX; Perlin DS; Marr KA
Antimicrob Agents Chemother; 2014 Sep; 58(9):5421-7. PubMed ID: 24982083
[TBL] [Abstract][Full Text] [Related]
27. Emergence of the novel sixth
Khan T; Faysal NI; Hossain MM; Mah-E-Muneer S; Haider A; Moon SB; Sen D; Ahmed D; Parnell LA; Jubair M; Chow NA; Chowdhury F; Rahman M
Microbiol Spectr; 2024 Jul; 12(7):e0354023. PubMed ID: 38842332
[No Abstract] [Full Text] [Related]
28. Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to Echinocandins in Candida glabrata.
Pham CD; Bolden CB; Kuykendall RJ; Lockhart SR
J Clin Microbiol; 2014 Mar; 52(3):790-5. PubMed ID: 24353003
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
[TBL] [Abstract][Full Text] [Related]
30.
Vatanshenassan M; Boekhout T; Meis JF; Berman J; Chowdhary A; Ben-Ami R; Sparbier K; Kostrzewa M
Front Cell Infect Microbiol; 2019; 9():20. PubMed ID: 30834236
[No Abstract] [Full Text] [Related]
31. Novel
Hou X; Healey KR; Shor E; Kordalewska M; Ortigosa CJ; Paderu P; Xiao M; Wang H; Zhao Y; Lin LY; Zhang YH; Li YZ; Xu YC; Perlin DS; Zhao Y
Emerg Microbes Infect; 2019; 8(1):1619-1625. PubMed ID: 31711370
[TBL] [Abstract][Full Text] [Related]
32. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
[TBL] [Abstract][Full Text] [Related]
33.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
34. Delineation of the Direct Contribution of Candida auris
Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
[TBL] [Abstract][Full Text] [Related]
35. Acquired echinocandin resistance in a Candida krusei blood isolate confirmed by mutations in the fks1 gene.
Prigitano A; Esposito MC; Cogliati M; Pitzurra L; Santamaria C; Tortorano AM
New Microbiol; 2014 Apr; 37(2):237-40. PubMed ID: 24858652
[TBL] [Abstract][Full Text] [Related]
36.
Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
[TBL] [Abstract][Full Text] [Related]
37. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
[TBL] [Abstract][Full Text] [Related]
38. Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.
Ben-Ami R; Garcia-Effron G; Lewis RE; Gamarra S; Leventakos K; Perlin DS; Kontoyiannis DP
J Infect Dis; 2011 Aug; 204(4):626-35. PubMed ID: 21791665
[TBL] [Abstract][Full Text] [Related]
39. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
40. Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil.
Spruijtenburg B; Nobrega de Almeida Júnior J; Ribeiro FC; Kemmerich KK; Baeta K; Meijer EFJ; de Groot T; Meis JF; Colombo AL;
Mycoses; 2024 Jun; 67(6):e13752. PubMed ID: 38880933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
